Drug Shortage Report for MINT-LACOSAMIDE
| Report ID | 131336 |
| Drug Identification Number | 02490544 |
| Brand name | MINT-LACOSAMIDE |
| Common or Proper name | Lacosaminde |
| Company Name | MINT PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | LACOSAMIDE |
| Strength(s) | 50MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 60 count bottles |
| ATC code | N03AX |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2021-01-11 |
| Estimated end date | |
| Actual end date | 2021-02-10 |
| Shortage status | Resolved |
| Updated date | 2021-02-23 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2021-01-11 | English | Compare |
| v2 | 2021-01-11 | French | Compare |
| v3 | 2021-01-12 | English | Compare |
| v4 | 2021-02-23 | English | Compare |
| v5 | 2021-02-23 | French | Compare |
Showing 1 to 5 of 5